FH and tuberculosis: Novel approaches towards new anti-TB agents in our laboratories have focused heavily on structure-based design against new targets, a recent case in point [35,36] being Mtb fumarate hydratase (fumarase) in which inhibitors with a dimeric binding mode at an allosteric site were utilized to affect Mtb viability.